BioNeex
Bioneex identifies and licenses drug candidates for further development and commercialization.
Launch date
Employees
Market cap
-
Enterprise valuation
$2—3m (Dealroom.co estimates Feb 2024.)
Company register number HRB 193002 B (Charlottenburg (Berlin))
Syracuse New York (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m |
| % growth | - | 20 % | 100 % | - |
| EBITDA | - | <1m | - | - |
| % EBITDA margin | - | 4 % | - | - |
| Profit | - | <1m | - | - |
| % profit margin | - | 4 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
$70.0k | Seed | ||
N/A | Seed | ||
* | N/A | $500k | Seed |
| Total Funding | $570k | ||
Related Content
Recent News about BioNeex
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.